期刊文献+

HBsAgS与GM-CSF融合基因在L929细胞中的表达 被引量:2

Expression of HBsAg S and GM CSF fusion gene in L929 cells
原文传递
导出
摘要 将乙肝病毒表面抗原(HBsAg) 主蛋白的编码基因S与人GMCSF 基因融合后, 插入真核表达质粒pcDNA1 中, 经质粒酶切鉴定及DNA 序列分析证明, 目的基因(1. 1kb) 插入pcDNA1 的CMV 启动子下游。以获得的重组质粒pSGM 转染L929 细胞, 经RTPCR 及细胞原位杂交证实了目的基因的转录。通过免疫组化技术, 利用抗HBs 和GMCSF抗体, 检出目的基因在L929 细胞中的表达。该结果为用乙型肝炎病毒的基因免疫打下了基础。 HBV S gene encoding major envelope protein was fused with human GM CSF gene and inserted into eukaryotic expression plasmid pcDNA1. Enzyme digestion and DNA sequencing analysis showed that the 1.1 Kb target gene was inserted into downstream of the CMV promoter. Then the recombinant plasmid pSGM was transfected into L929 cells. The gene transcription was confirmed by RT PCR and cell in situ hybridization and the gene products was demonstrated by immunohistochemical staining with anti HBs and anti GM CSF antibody. Above results lay the foundation for the gene immunization of HBV.
出处 《细胞与分子免疫学杂志》 CAS CSCD 1999年第4期259-262,共4页 Chinese Journal of Cellular and Molecular Immunology
关键词 HBsAgS GM-CSF L929细胞 基因表达 融合基因 HBsAg S gene GM CSF L929 cell gene expression
  • 相关文献

参考文献2

  • 1Jones T,Eur J Microbiol Infect Dis,1994年,5卷,363页
  • 2苏慧慈,原位杂交,1994年,115页

同被引文献13

  • 1萨姆布鲁布 J 金冬雁(译).分子克隆实验指南(第二版)[M].北京:科学技术出版社,1992.1-320.
  • 2Pride MW, Bailey CR, Muchmore E, et al. Evaluation of B and T-cell responses in chimpanzees immunized with hepagene, a hepatitis B vaccine containing preS1, preS2 and S gene products[J]. Vaccine, 1988,16(6):543 ~ 550.
  • 3Kwissa M, Kroger A, Hauser H, et al. Cytokine-facilitated priming of CD8(+)T cell DNA vaccination[J] .J Mol Med,2003,81(2) :91 ~ 101.
  • 4Sun X, Hodge LM, Jones HP, et al. Co-expression of granulocytemacrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination [J]. Vaccine, 2002, 20 ( 9 ~ 10):1466 ~ 1474.
  • 5Burger JA, Mendoza RB, Kipps TJ. Plasmids encoding granulocyte macrophage colony-stimulating factor and CD154 enhance the immune response to genetic vaccines[J] .Vaccine,2001,19(15 ~ 16):2181 ~ 2189.
  • 6Haubitz M, Ehlerding G, Beigel A, et al. Clinical experience with a new recombinant hepatitis B vaccine in previous non-responders with chronic renal insufficiency[J]. Clin Nephrol, 1996,45(3):180 ~ 182.
  • 7Geissler M,Tokushige K, Chante CC, et al. Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization[J]. Gastroenterology, 1997,112(4): 1307 ~ 1320.
  • 8Pol S,Nalpas B,Driss F, et al. Efficacy and limitations of a specific immunotherapy in chronic hepatitis B[ J]. J Hepatol,2001,34(6):917~ 921.
  • 9Wong GG,Witek JS,Temple PA, et al. Human GM-CSF: Molecular cloning of the complementary DNA and purification of the natural and the recombinant proteins[J]. Science, 1985,228: 810 ~ 815.
  • 10张彤,张光磊,阮丽荣,张绍祖.细胞因子对乙肝病毒基因疫苗诱导产生抗体的影响[J].中华微生物学和免疫学杂志,1997,17(6):421-424. 被引量:11

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部